Growth enhancement in broiler chickens receiving CHEMEQ(RTM) polymeric antimicrobial

This study investigated the use of CHEMEQ(RTM) polymeric antimicrobial as a means of enhancing health and growth rates in broiler chickens. One-day-old Cobb-500 broilers were reared to 42 days. In trial 1, 100 birds received CHEMEQ(RTM) polymeric antimicrobial via water, and 100 birds were untreated. Treated birds had significantly greater (P < 0.0001) average daily gain (ADG), significantly lower (P < 0.0016) feed conversion ratios, significantly lower (P < 0.05) mortality, and a significantly lower (P < 0.0042) viscosity of their ileal contents. In trial 2, three groups of 40 birds received reducing dosages of CHEMEQ(RTM) polymeric antimicrobial, and a fourth group remained untreated. Groups receiving CHEMEQ(RTM) polymeric antimicrobial had significantly greater (P < 0.05) ADG, and two groups had significantly lower (P< 0.05) feed conversion ratios than the controls. In trial 3, groups of 40 birds received either CHEMEQ(RTM) polymeric antimicrobial, Salinomycin or Lasalocid in-feed, or were untreated. Birds receiving CHEMEQ(RTM) polymeric antimicrobial had significantly greater (P< 0.05) ADG than those receiving Salinomycin. CHEMEQ(RTM) polymeric antimicrobial helped to maintain the health and to improve the growth performance of broiler chickens.